Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated to v3.4.2 and the earlier v3.4.1 funding/operational notice was removed. No study-related content, eligibility criteria, or results were changed.SummaryDifference0.5%

- Check20 days agoChange DetectedAdded a public notice about a lapse in government funding and updated the page revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedGlossary UI is now shown and new QC-related metadata labels were added (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with Revision updated to v3.4.0. The older label Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.3%

- Check35 days agoChange DetectedDifference0.3%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no other content changes are evident.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section now lists Colorado, Michigan, Texas, and Washington as study sites, and the page revision is updated to v3.3.3. The HHS Vulnerability Disclosure link and the prior state location entries were removed in this update.SummaryDifference0.6%

Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.